Covid-19 in adolescent patients in the Brazilian population with sickle cell anemia
A Review
DOI:
https://doi.org/10.31686/ijier.vol10.iss1.3622Keywords:
COVID-19, sickle cell anemia, Coronavirus, Sickle-cell anemia, TreatmentAbstract
Introduction: Sickle cell anemia due to recent scientific evidence suggests that individuals with disease are considered a risk group and SARS-CoV-2 and spreads rapidly in this group of patients with diseases due to lack of inherited immunity, has a high lethality rate among young people and children and patients with associated comorbidities such as Diabetes Mellitus. Objective: to analyze the profile of patients with sickle cell anemia and their immunological motivations for worsening in positive cases of COVID-19 from a systematic review. Results: Initially, 217 articles were identified, of which 213 were removed because they were not related to the theme of the review, or because they were duplicated or did not have the abstract. The 04 selected articles were classified into two thematic axes to be performed the analysis. Discussion: This systematic review study is the first with sickle cell anemia and COVID-19 in the adolescent population with a limited resource configuration that shows the inherent need in the management of both diseases. However, in this systematic review, the four included studies showed a favorable evolution of the infectious process by COVID-19, and deaths occurred in adolescent patients who concomitantly had multiple comorbidities, for example, DM. Conclusion: It was found in this systematic review study that COVID-19 infection may accentuate the presence of vasculopathy in patients with sickle cell anemia and may increase pain to varying degrees.
Downloads
References
Naik RP, Streiff MB, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013; 35(3):352–8. DOI: 10.1007/s11239-013-0895-y DOI: https://doi.org/10.1007/s11239-013-0895-y
Johnston RB Jr, Newman SL, Struth AG. Increased susceptibility to infection in sickle cell disease: defects of opsonization and of splenic function. Birth Defects Orig Artic Ser. 1975; 11(1):322–7. PMID: 238677.
Hussain FA, Njoku FU, Saraf SL, Molokie RE, Gordeuk VR, Han J. COVID-19 infection in patients with sickle cell disease. Br J Haematol. 2020; 189(5):851–852. DOI: https://doi.org/10.1111/bjh.16734
From Luna Gonzalo, Habibi Anoosha, Deux Jean-Franc_ois, Colard Martin, Pham Hung d'Alexandry d'Orengiani Anne-Laure, Schlemmer Fr_ed_eric, Joher Nizar, Christian Kassasseya, Pawlotsky Jean Michel, Ourghanlian Cl_ement, Michel Marc, Mekontso-Dessap Armand, Pablo Bartolucci. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab. Am J Hematol. 2020; 95(7):876–878. DOI: https://doi.org/10.1002/ajh.25833
Heilbronner C, Berteloot L, Tremolieres P, Dupic L, De Saint Blanquat L, Lesage F et al Patients with Sickle cell disease and suspected COVID-19 in a pediatric ICU. Br J Haematol. 2020. DOI: https://doi.org/10.1111/bjh.16802
Odievre MH, by Marcellus C, Ducou Le Pointe H, Allali S, Romain AS, Youn J et al Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome. Am J Hematol. 2020. DOI: https://doi.org/10.1002/ajh.25855
Nur E, Gaartman AE, van Tuijn CFJ, Tang MW, Biemond BJ. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19). Am J Hematol. 2020; 95 (6):725–6. DOI: https://doi.org/10.1002/ajh.25821
Deza Leon, M.P.; Redzepi, A.; McGrath, E.; Abdel-Haq, N.; Shawaqfeh, A.; Sethuraman, U.; Tilford, B.; Chopra, T.; Arora, H.; Ang, J.; et al. COVID-19-Associated Pediatric Multisystem Inflammatory Syndrome. J. Pediatric Infect. Dis. Soc. 2020, 9, 407–408. DOI: https://doi.org/10.1093/jpids/piaa061
McCloskey KA, Meenan J, Hall R, Da Tsitsikas. COVID-19 infection and sickle cell disease: a UK centre experience. Br J Haematol. 2020. DOI: https://doi.org/10.1111/bjh.16779
Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay D. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient. Am J Hematol. 2020. DOI: https://doi.org/10.1002/ajh.25809
Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020. DOI: https://doi.org/10.1111/bjh.16880
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020. DOI: https://doi.org/10.1001/jama.2020.6775
Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020;21 (6):e13034. DOI: https://doi.org/10.1111/obr.13034
Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang YQ et al Lymphopeni predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020; 5(1):33. DOI: https://doi.org/10.1038/s41392-020-0159-1
Cron RQ, Chatham WW. The Rheumatologist's role in COVID-19. J Rheumatol. 2020; 47(5):639–42. DOI: https://doi.org/10.3899/jrheum.200334
Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML et al Benefit of Anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis Arthritis Rheumatol. 2020;72(2):326–34. DOI: https://doi.org/10.1002/art.41103
Esposito, S.; Marchetti, F.; Lanari, M.; Caramelli, F.; From Fanti, A.; Vergine, G.; Iughetti, L.; Fornaro, M.; Suppiej, A.; Zone, S.; et al. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy. Int. J. Environ. Res. Public Health 2021, 18, 3919. https://doi.org/10.3390/ijerph18083919 DOI: https://doi.org/10.3390/ijerph18083919
APPIAH-KUBI et al. Varying presentations and favorable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparison to published cases. British Society for Haematology and John Wiley & Sons Ltd. 2020. https://doi.org/10.1111/ibjh.17013. DOI: https://doi.org/10.1111/bjh.17013
Oliveira et al. Educational technology on COVID-19 for families of children and adolescents with sickle cell disease. Rev Bras Enferm. 2021; 74(Suppl 1): https://doi.org/10.1590/0034-7167-2020-1045 e20201045. DOI: https://doi.org/10.1590/0034-7167-2020-1045
F.G.F. Rocha, A.L.J.F. Campos, M.R.F. Teixeira, M.G. Vanderlei, L.F.B. Botelho. INFECTION BY COVID-19 AND SICKLE DISEASE ANEMIA: A LITERATURE REVIEW. Hematol transfuse cell ther. 2020; 42(S 2):S1–S567. DOI: https://doi.org/10.1016/j.htct.2020.10.912
Langford, B.J.; So, M.; Raybardhan, S.; Leung, V.; Westwood, D.; MacFadden, D.R.; Soucy, J.R.; Daneman, N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Get infected. 2020, 26.1622–1629. DOI: https://doi.org/10.1016/j.cmi.2020.07.016
SANTOS, C.M.C.; PEPPER, C.A.M.; NOBLE, M.R.C.N. The PICO strategy for the construction of the research question and search for evidence. Latin American journal of nursing. v.15. n.3. 2007. DOI: https://doi.org/10.1590/S0104-11692007000300023
DE-LA-TORRE-UGARTE-GUANILO, M.C.; TAKAHASHI, R.F.; BERTOLOZZI, M. R. Systematic review: general concepts. Journal of the School of Nursing USP. v. 45, n. 5, p. 1260 - 1266, Oct. 2011. DOI: https://doi.org/10.1590/S0080-62342011000500033
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Felipe Zampieri Vieira Batista, Igor Domingos de Souza, Francisco José Mendes dos Reis Ramos; Hugo Vieira Ramos; Liliane Moretti Carneiro, Maria Lúcia Ivo , Alexandra Maria Almeida Carvalho, Priscila Gonçalves Soares dos Santos, Valdir Aragão Nascimento
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
Accepted 2022-01-01
Published 2022-01-01
